Overview

A Prospective,Open-label Study of Anastrozole in Post-menopausal Women With Hormone Sensitive Advanced Breast Cancer

Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The overall objective of the clinical study is to assess the tolerability and clinical efficacy of anastrozole in post-menopausal women with hormone sensitive advanced breast cancer in India.
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Anastrozole
Hormones